Smith & Nephew plc (SNN)
34.36
+0.53
(+1.57%)
USD |
NYSE |
Apr 17, 16:00
34.34
-0.02
(-0.04%)
After-Hours: 20:00
Smith & Nephew Enterprise Value : 16.20B for April 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | 475.20M |
| Akari Therapeutics Plc | 2.130M |
| NuCana Plc | -22.34M |
| Mereo BioPharma Group Plc | 12.73M |
Enterprise Value Related Metrics
| Earnings Yield | 4.18% |
| Operating Earnings Yield | 6.91% |
| Normalized Earnings Yield | 5.304 |